TransMedics Group, Inc. (TMDX): Price and Financial Metrics

TransMedics Group, Inc. (TMDX): $52.78

1.97 (-3.60%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

TMDX Price/Volume Stats

Current price $52.78 52-week high $99.63
Prev. close $54.75 52-week low $38.86
Day low $52.27 Volume 1,490,400
Day high $54.99 Avg. volume 594,997
50-day MA $67.07 Dividend yield N/A
200-day MA $71.67 Market Cap 1.72B

TMDX Stock Price Chart Interactive Chart >

TMDX POWR Grades

  • Growth is the dimension where TMDX ranks best; there it ranks ahead of 80.49% of US stocks.
  • TMDX's strongest trending metric is Value; it's been moving up over the last 177 days.
  • TMDX ranks lowest in Stability; there it ranks in the 2nd percentile.

TMDX Stock Summary

  • TMDX's price/sales ratio is 11.96; that's higher than the P/S ratio of 91.78% of US stocks.
  • With a year-over-year growth in debt of 1,044.54%, TRANSMEDICS GROUP INC's debt growth rate surpasses 98.8% of about US stocks.
  • As for revenue growth, note that TMDX's revenue has grown 193.7% over the past 12 months; that beats the revenue growth of 96.84% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to TRANSMEDICS GROUP INC are AUPH, INVE, NTRB, NXGN, and POLA.
  • TMDX's SEC filings can be seen here. And to visit TRANSMEDICS GROUP INC's official web site, go to www.transmedics.com.

TMDX Valuation Summary

  • TMDX's price/sales ratio is 12; this is 200% higher than that of the median Healthcare stock.
  • Over the past 53 months, TMDX's price/sales ratio has gone down 21.1.

Below are key valuation metrics over time for TMDX.

Stock Date P/S P/B P/E EV/EBIT
TMDX 2023-09-22 12.0 12.4 -101.6 -141.1
TMDX 2023-09-21 12.3 12.8 -104.7 -145.6
TMDX 2023-09-20 12.4 12.9 -105.5 -146.7
TMDX 2023-09-19 12.6 13.2 -107.4 -149.5
TMDX 2023-09-18 12.7 13.2 -108.1 -150.5
TMDX 2023-09-15 12.9 13.4 -109.3 -152.1

TMDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TMDX has a Quality Grade of D, ranking ahead of 12.13% of graded US stocks.
  • TMDX's asset turnover comes in at 0.2 -- ranking 143rd of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows TMDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.200 0.677 -0.179
2021-03-31 0.162 0.659 -0.164
2020-12-31 0.179 0.649 -0.186
2020-09-30 0.183 0.646 -0.227
2020-06-30 0.202 0.609 -0.280
2020-03-31 0.243 0.610 -0.314

TMDX Price Target

For more insight on analysts targets of TMDX, see our TMDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $53.00 Average Broker Recommendation 1.5 (Moderate Buy)

TransMedics Group, Inc. (TMDX) Company Bio


TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.


TMDX Latest News Stream


Event/Time News Detail
Loading, please wait...

TMDX Latest Social Stream


Loading social stream, please wait...

View Full TMDX Social Stream

Latest TMDX News From Around the Web

Below are the latest news stories about TRANSMEDICS GROUP INC that investors may wish to consider to help them evaluate TMDX as an investment opportunity.

Checking In on the Fed, FedEx, and TransMedics

What metrics the Fed is looking at before its next meeting. How FedEx's business has evolved over time. Deidre and Motley Fool analyst Tom King explore how TransMedics is building a complete organ transplantation supply chain.

Yahoo | September 28, 2023

3 Best Stocks to Buy With $300 Right Now

Whether driven by unstoppable megatrends or wide moats, these three stocks are poised to continue growing.

Yahoo | September 28, 2023

TransMedics Group, Inc.'s (NASDAQ:TMDX) Shift From Loss To Profit

With the business potentially at an important milestone, we thought we'd take a closer look at TransMedics Group...

Yahoo | September 22, 2023

Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains

Unearth the best healthcare stocks to buy that are poised for long-term growth ahead for savvy investors at this time

Muslim Farooque on InvestorPlace | September 13, 2023

The 3 Most Promising Healthcare Stocks to Own Now

These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

Charles Munyi on InvestorPlace | September 1, 2023

Read More 'TMDX' Stories Here

TMDX Price Returns

1-mo -23.64%
3-mo -35.49%
6-mo -27.85%
1-year 24.98%
3-year 278.89%
5-year N/A
YTD -14.48%
2022 222.13%
2021 -3.72%
2020 4.68%
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!